Technical Analysis for ALBO - Albireo Pharma, Inc.

Grade Last Price % Change Price Change
grade D 23.8 -8.53% -2.22
ALBO closed down 8.53 percent on Friday, August 23, 2019, on 1.93 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ALBO trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Shooting Star Candlestick Bearish -8.53%
1,2,3 Retracement Bearish Bearish Swing Setup -8.53%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -8.53%
Stochastic Reached Overbought Strength -8.53%
Overbought Stochastic Strength -8.53%
1,2,3 Retracement Bearish Bearish Swing Setup -9.85%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -9.85%
20 DMA Support Bullish -9.85%
Outside Day Range Expansion -9.85%

Older signals for ALBO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Albireo Limited is a holding company for Albireo AB, a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo’s clinical pipeline includes two Phase 2 product candidates and one Phase 3 product candidate. Albireo was spun out from AstraZeneca in 2008 and is backed by top-tier life science investors such as Phase4 Ventures, TPG Biotech, TVM Capital Life Science and Aberdeen Asset Management, as well as AstraZeneca. Albireo Limited is incorporated and registered in England and Wales, and its wholly owned subsidiaries are located in Gothenburg, Sweden and Boston, Massachusetts. For more information on Albireo, please visit www.albireopharma.com
Biopharmaceutical Life Sciences Disorders Astrazeneca Liver Södertälje Municipality
Is ALBO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 38.69
52 Week Low 19.1
Average Volume 59,528
200-Day Moving Average 28.6281
50-Day Moving Average 28.1148
20-Day Moving Average 24.727
10-Day Moving Average 24.085
Average True Range 1.7038
ADX 37.58
+DI 18.8016
-DI 28.1573
Chandelier Exit (Long, 3 ATRs ) 23.4186
Chandelier Exit (Short, 3 ATRs ) 25.2714
Upper Bollinger Band 27.7757
Lower Bollinger Band 21.6783
Percent B (%b) 0.35
BandWidth 24.658875
MACD Line -0.9579
MACD Signal Line -1.3353
MACD Histogram 0.3774
Fundamentals Value
Market Cap 211.39 Million
Num Shares 8.88 Million
EPS -6.29
Price-to-Earnings (P/E) Ratio -3.78
Price-to-Sales 70.91
Price-to-Book 3.07
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.49
Resistance 3 (R3) 27.90 27.07 26.88
Resistance 2 (R2) 27.07 26.13 26.87 26.67
Resistance 1 (R1) 25.44 25.55 25.03 25.03 26.46
Pivot Point 24.61 24.61 24.41 24.41 24.61
Support 1 (S1) 22.98 23.67 22.57 22.57 21.14
Support 2 (S2) 22.15 23.09 21.95 20.93
Support 3 (S3) 20.52 22.15 20.73
Support 4 (S4) 20.11